Asia Catalyst Update
May 2011
Here’s what we did with your help in the last quarter. Our work to help grassroots Asian AIDS groups to survive
and thrive is going strong. But we need your help to help others. Please give: www.asiacatalyst.org/donate
Asia Catalyst quoted in the New York Times this week, here: https://nyti.ms/kgTdfH
With the beginning of the new year, Asia Catalyst paved the ground for rapid growth of our capacity building program in China and Southeast Asia. This year in China, Asia Catalyst will begin short-term capacity-building partnerships of three to six months with seven new Chinese NGOs run by drug users, sex workers, and LGBT people — all communities directly affected by HIV/AIDS.
This year, an expanded technical assistance grant allowed us to issue a general call for applications from grassroots NGOs in China that want to strengthen their organizational management skills and build their future stability.
Missed our panel at the Asia Society on HIV/AIDS and human rights? You can watch the video (1 hr, 20 minutes) online at the link below.
NEW YORK, December 1, 2010 – Joseph Amon, Joanne Csete, Sara L.M. Davis, Kevin Robert Frost, Daniel Wolfe explore human rights issues as they relate to AIDS in Asia. (1 hr., 20 min.)
There was a visible presence for China during AIDS 2010, which included a delegation of non-governmental organizations (NGOs) from the country. Chinese officials also presented on the government’s work on HIV/AIDS, which elicited critical feedback from activists. In this article from the HIV/AIDS Policy and Law Review, conference attendees Sara L. M. Davis and Li Dan outline the main human rights issues in China’s response to HIV/AIDS.
* * *
By Gisa Hartmann
In response to the rise of drug dependence, China has begun to embrace harm reduction,
scaling up policies such as methadone maintenance treatment (MMT) and needle
exchange programs (NEP) in a growing number of areas. This shift in policy is expressed
in the new Anti-Drug Law, which categorizes drug addiction as a medical condition rather than a criminal issue or moral failing. But how far along is the development of MMT and NEP in China, and what does the state plan
for the future? How do current policies play out for drug users on the ground? This
two-part blog will explore these and related issues.
